Skip to main content
. 2019 Feb 22;25(8):1428–1441. doi: 10.1093/ibd/izy403

TABLE 1.

Characteristics of Patients


All Children
All Adults
Mean ± SD Total CD UC IBDU UC+IBDU Total CD UC IBDU UC+IBDU
Mean ± SD Mean ± SD
Subjects, No. (%) 203 179 (88.2) 4 (2.0) 20 (9.9) 24 (11.8) 387 274 (70.8)c 97 (25.1)c 16 (4.1)a 113 (29.2)c
Visits, No. 5.6 ± 2.8 5.9 ± 2.7 2.8 ± 2.2g 3.7 ± 2.3h 3.5 ± 2.3g 3.5 ± 3.0c 4.0 ± 3.0c 2.3 ± 2.7i 2.9 ± 2.8 2.4 ± 2.7i
Age at visit, y 13.9 ± 2.8 13.9 ± 2.7 14.9 ± 2.7 13.8 ± 3.9 13.9 ± 3.8 28.7 ± 13.2c 27.4 ± 12.4c 35.8 ± 15.3a,i 27.3 ± 10.9c,j 34.3 ± 15.0c,i
Age at diagnosis, y 11.4 ± 3.5 11.6 ± 3.2 12.9 ± 3.6 9.2 ± 4.8h 10.0 ± 4.8g 23.4 ± 13.1c 20.9 ± 11.3c 30.7 ± 15.5a,i 21.9 ± 10.7c,j 29.4 ± 15.2c,i
Follow-up duration, y 2.8 ± 2.2 2.8 ± 2.2 1.4 ± 1.1 3.83 ± 2.78g 3.3 ± 2.7 9.8 ± 8.7c 9.8 ± 8.5c 10.0 ± 9.7 7.0 ± 6.7 9.6 ± 9.4a
BMI, kg/m2 19.9 ± 4.0 19.8 ± 3.9 23.0 ± 5.6 21.6 ± 4.8 21.8 ± 4.9g 23.1 ± 4.3c 23.0 ± 4.3 23.5 ± 4.7 22.8 ± 2.6 23.6 ± 4.4
Male Children Male Adults
Total CD UC IBDU UC+IBDU Total CD UC IBDU UC+IBDU
Mean ± SD Mean ± SD
Subjects, No. (%) 114 (56.2) 105 (92.1) 0 (0) 9 (7.9) 9 (7.9) 195 (50.4) 141 (72.3)c 51 (26.2)c 3 (1.5)a 54 (27.7)c
Visits, No. 5.6 ± 2.7 5.9 ± 2.6 N/A 2.2 ± 1.0i 2.2 ± 1.0i 3.4 ± 2.9c 3.9 ± 3.0c 1.8 ± 1.5i 4.0 ± 4.4 1.9 ± 1.7i
Age at visit, y 14.1 ± 2.5 14.2 ± 2.3 N/A 9.7 ± 4.7i 9.7 ± 4.7i 28.9 ± 14.4c 27.1 ± 12.9c 41.1 ± 17.2i 20.9 ± 7.2a,j 38.8 ± 17.9c,i
Age at diagnosis, y 11.3 ± 3.6 11.8 ± 3.2 N/A 3.6 ± 1.5i 3.6 ± 1.5i 24.4 ± 13.7c 21.2 ± 11.5c 33.6 ± 15.4i 14.5 ± 5.5b,j 32.6 ± 15.9c,i
Follow-up duration, y 3.0 ± 2.3 3.0 ± 2.3 N/A 3.3 ± 3.9 3.3 ± 3.9 9.2 ± 8.0c 9.2 ± 8.1c 9.1 ± 8.0 10.0 ± 7.9 9.2 ± 7.9a
BMI, kg/m2 20.1 ± 3.6 20.2 ± 3.6 N/A 19.3 ± 3.9 19.3 ± 3.9 23.6 ± 4.6c 23.2 ± 4.3c 25.9 ± 6.0h 24.00 ± 1.8 25.6 ± 5.7a,h
Female Children Female Adults
Total CD UC IBDU UC+IBDU Total CD UC IBDU UC+IBDU
Mean ± SD Mean ± SD
Subjects, No. (%) 89 (43.8) 74 (83.2) 4 (4.5) 11 (12.4) 15 (16.9) 192 (49.6) 133 (69.3)c 46 (24.0)c 13 (6.8)d 59 (30.7)a
Visits, No. 5.6 ± 2.9 5.9 ± 2.9 2.8 ± 2.2g 4.8 ± 2.4e 4.3 ± 2.5g,d 3.7 ± 3.1c 4.1 ± 2.9c 2.9 ± 3.6g,d 2.7 ± 2.5a 2.8 ± 3.3h
Age at visit, y 13.6 ± 3.0 13.3 ± 3.0 14.9 ± 2.7 15.3 ± 2.1d,g 15.2 ± 2.2e,g 28.6 ± 12.1c 27.6 ± 11.8c 32.1 ± 12.7a,d,g 29.4 ± 11.2b 30.6 ± 12.4c,d
Age at diagnosis, y 11.5 ± 3.3 11.39 ± 3.42 12.9 ± 3.6 11.8 ± 3.5f 12.1 ± 3.3f 22.5 ± 12.4c 20.7 ± 11.0c 27.4 ± 15.2d,h 23.6 ± 11.0a 26.5 ± 14.4b,d,g
Follow-up duration, y 2.6 ± 2.1 2.4 ± 2.0 1.4 ± 1.1 4.1 ± 2.3g,j 3.4 ± 2.4 10.4 ± 9.3c 10.5 ± 8.7c 10.9 ± 11.4 6.4 ± 6.5 9.9 ± 10.6a
BMI, kg/m2 19.7 ± 4.4 19.3 ± 4.2 23.0 ± 5.9 22.4 ± 4.9g 22.5 ± 4.9g 22.5 ± 3.9c 22.7 ± 4.2c 21.8 ± 2.4f 22.3 ± 2.7 22.0 ± 4.5e

Characteristics of IBD patients grouped as CD, UC, or IBDU according to the Montreal classification. Subjects age 16 years and younger were classified as pediatric and 17 years and older as adults. The average of BMI captured at each visit is presented.

a P < 0.05, bP < 0.001, cP < 0.0001 vs children.

d P < 0.05, eP < 0.001, fP < 0.0001 vs male.

g P < 0.05, hP < 0.001, iP < 0.0001 vs CD.

j P < 0.05 vs UC.